Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Transfus Apher Sci ; 36(1): 103-7, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17224307

RESUMO

Therapeutic plasma exchange (TPE) has been used for the treatment of neurologic diseases in which autoimmunity plays a major role. We reviewed the medical records of our patients who had consecutively been treated by TPE between January 1998 and June 2000. Neurological indications included myasthenia gravis (30 patients), multiple sclerosis attack (6 patients with remitting-relapsing course and 3 patients with secondary progressive course), Guillain-Barrè syndrome (6 patients), paraproteinemic neuropathy (2 patients), and chronic inflammatory demyelinating neuropathy (CIDP), transverse myelitis due to systemic lupus erythematosus, acute disseminated encephalomyelitis in one patient each. Continuous flow cell separators were used for TPE. TPE was generally given every other day for all of the patients and one plasma volume was exchanged for each cycle. Although the patients with secondary progressive multiple sclerosis (3 patients) and paraproteinemic neuropathy (2 patients) did not show any improvement after TPE, other patients' targeted neurological deficits were improved by TPE. During the TPE procedures, no patient had any morbidity or mortality, and the complications were mild and manageable such as hypotension, hypocalcemia and mild anemia; three patients had septicemia due to the venous catheter used for TPE. TPE is an effective treatment in neurologic diseases in which autoimmunity plays an important role in pathogenesis, and it is safe when performed in experienced centers.


Assuntos
Doenças Autoimunes do Sistema Nervoso/terapia , Troca Plasmática , Anemia/etiologia , Anemia/terapia , Doenças Autoimunes do Sistema Nervoso/complicações , Humanos , Hipocalcemia/etiologia , Hipocalcemia/terapia , Hipotensão/etiologia , Hipotensão/terapia , Troca Plasmática/efeitos adversos , Indução de Remissão , Estudos Retrospectivos , Sepse/etiologia , Sepse/terapia
3.
Clin Neurol Neurosurg ; 107(3): 249-52, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15823684

RESUMO

Idiopathic hypertrophic cranial pachymeningitis (IHCP) consists of meningeal thickening due to chronic inflammation for which no cause such as infection, specific granulomatous disease, or malignancy is demonstrable. We present a case of IHCP with perifocal brain edema suggesting mass lesion with its magnetic resonance imaging (MRI) and pathologic findings. A 36-year-old woman was admitted to our hospital in August 2001 with a complaint of motor weakness in her left leg for 1 month. Magnetic resonance imaging with gadolinium revealed enhancement of the thickened dura mater and perifocal edema in the right frontoparietal region suggesting a mass lesion. Histological examination of the biopsy specimen revealed a dense fibrous cellular tissue. There was no obvious inflammatory infiltrate but in some areas between fibrous bundles one or two lymphocytes were detected. According to our knowledge, our patient is the second report in the literature of IHCP with focal edema causing a mass effect.


Assuntos
Edema Encefálico/patologia , Dura-Máter/patologia , Meningite/patologia , Adulto , Edema Encefálico/etiologia , Feminino , Humanos , Hipertrofia/complicações , Hipertrofia/patologia , Meningite/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...